Uso de vacuna valergen DP en la rinitis alérgica

Sugrañes Montalván, Adianez; Hernández Veiga, Marelys; Morales Menéndez, María; Barreto Suárez, Eduardo; Sugrañes Montalván, Arianna; Ramírez Torres, Andrés.
Arch. méd. Camaguey ; 15(4)oct. 2010. graf
Artículo en Español | LILACS | ID: lil-615948

Documentos relacionados

  1. Antigen-specific active immunotherapy for ovarian cancer.
  2. Induced pluripotent stem cell-derived dendritic cell vaccine therapy genetically modified on the ubiquitin-proteasome system.
  3. Safety and efficacy of active and passive immunotherapy in mild-to-moderate Alzheimer's disease: A systematic review and network meta-analysis.
  4. Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer.
  5. Vacuna terapéutica racotumomab en un anciano con cáncer avanzado de pulmón
  6. Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived free-VEGF.
  7. SnapShot: Natural Killer Cells.
  8. Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials.
  9. mRNA: A Versatile Molecule for Cancer Vaccines.
  10. Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance.